![](/img/cover-not-exists.png)
The use of granuloctye colony-stimulating factor to deliver four cycles of ifosfamide and epirubicin every 14 days in women with advanced or metastatic breast cancer
Lind, MJ, Gumbrell, L, Cantwell, BMJ, Millward, MJ, Simmonds, D, Proctor, M, Chapman, F, McCann, E, Middleton, I, Calvert, AHVolume:
71
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.1995.118
Date:
March, 1995
File:
PDF, 690 KB
english, 1995